Timing of adjunctive therapy in the treatment of depression: a chart review

Pharmacopsychiatry. 2014 Nov;47(7):259-62. doi: 10.1055/s-0034-1387784. Epub 2014 Sep 2.

Abstract

Introduction: The objective of this study was to examine the evolution of antidepressant switch and adjunctive therapy.

Methods: This chart review was conducted at 6 primary psychiatric clinics or hospitals, in Tokyo, Japan. A chart review of longitudinal prescriptions was conducted regarding 633 outpatients with major depressive disorder for up to 2 years after their first visit. Patients who had already received antidepressants prior to the visit were excluded.

Results: 22.6% (N=143) of the patients completed or continued the outpatient treatment over the 2 years while 27 (4.3%), 23 (3.6%), and 439 (69.4%) patients discontinued it due to hospitalization, referral to another clinic, and loss to follow-up, respectively. A total of 597 episodes of antidepressant treatment were identified. Among them, 482 episodes (80.7%) were associated with the suggested dose ranges while antidepressant drugs were under-dosed in 19.3% (N=115) of the episodes. 50 patients (7.9%) received adjunctive therapy; it was employed after a median of only one antidepressant had been tried.

Conclusion: Psychiatrists may be hasty in prescribing an adjunctive therapy in the treatment of depression.

MeSH terms

  • Adult
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / therapeutic use*
  • Central Nervous System Agents / therapeutic use
  • Depressive Disorder, Major / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Hospitals, Psychiatric
  • Humans
  • Japan
  • Male
  • Middle Aged

Substances

  • Antidepressive Agents
  • Central Nervous System Agents